Trials / Completed
CompletedNCT01094392
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)
Influence on Hemostasis During Prolonged Asparaginase Treatment in Childhood and Adolescent ALL
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
Asparaginase is an important drug in the treatment of childhood leukemia. One of the rare but severe side effects to the treatment is thrombosis in or outside the central nervous system. The aim of this study is to investigate and describe the influence on the coagulation parameters during prolonged treatment with asparaginase. Hopefully this knowledge will help to foresee the risk of thrombosis and thus making it possible to prevent these.
Conditions
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2018-10-10
- Completion
- 2018-10-10
- First posted
- 2010-03-29
- Last updated
- 2021-01-13
Locations
4 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01094392. Inclusion in this directory is not an endorsement.